Arbutus Biopharma Corp. (ABUS)
4.45
-0.11
(-2.41%)
USD |
NASDAQ |
Oct 02, 16:00
4.475
+0.02
(+0.56%)
After-Hours: 20:00
Arbutus Biopharma Net Income (Quarterly) : -5.143M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.143M |
| March 31, 2026 | 169.70M |
| December 31, 2025 | -3.756M |
| September 30, 2025 | -7.742M |
| June 30, 2025 | 2.523M |
| March 31, 2025 | -24.53M |
| December 31, 2024 | -12.53M |
| September 30, 2024 | -19.72M |
| June 30, 2024 | -19.80M |
| March 31, 2024 | -17.88M |
| December 31, 2023 | -19.31M |
| September 30, 2023 | -20.10M |
| June 30, 2023 | -17.09M |
| March 31, 2023 | -16.34M |
| December 31, 2022 | -21.93M |
| September 30, 2022 | -17.57M |
| June 30, 2022 | -14.19M |
| March 31, 2022 | -15.76M |
| December 31, 2021 | -21.32M |
| September 30, 2021 | -19.16M |
| June 30, 2021 | -19.39M |
| March 31, 2021 | -16.38M |
| December 31, 2020 | -17.04M |
| September 30, 2020 | -18.76M |
| June 30, 2020 | -14.09M |
| Date | Value |
|---|---|
| March 31, 2020 | -13.86M |
| December 31, 2019 | -24.65M |
| September 30, 2019 | -82.50M |
| June 30, 2019 | -23.32M |
| March 31, 2019 | -23.25M |
| December 31, 2018 | -18.25M |
| September 30, 2018 | -24.47M |
| June 30, 2018 | 3.091M |
| March 31, 2018 | -17.43M |
| December 31, 2017 | -35.93M |
| September 30, 2017 | -11.60M |
| June 30, 2017 | -18.26M |
| March 31, 2017 | -18.63M |
| December 31, 2016 | -218.70M |
| September 30, 2016 | -19.60M |
| June 30, 2016 | -130.00M |
| March 31, 2016 | -15.87M |
| December 31, 2015 | -5.264M |
| September 30, 2015 | -28.98M |
| June 30, 2015 | -14.89M |
| March 31, 2015 | -11.99M |
| December 31, 2014 | -6.168M |
| September 30, 2014 | -8.604M |
| June 30, 2014 | -6.081M |
| March 31, 2014 | -17.98M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Insmed, Inc. | -13.24M |
| Pfizer Inc. | -246.00M |
| Gossamer Bio, Inc. | 16.90M |
| Legend Biotech Corp. | 33.25M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.014M |
| Total Expenses (Quarterly) | 6.157M |
| EPS Diluted (Quarterly) | -0.026 |
| Enterprise Value | 790.47M |
| Gross Profit Margin (Quarterly) | 98.92% |
| Profit Margin (Quarterly) | -507.2% |
| Earnings Yield | 17.60% |
| Operating Earnings Yield | 17.06% |
| Normalized Earnings Yield | 17.47 |